Pharmaceuticals have been one of the most buoyant industrial
markets in the last couple of years. Mott MacDonald is the leading
designer of pharmaceutical plants in India today. We have worked
for most of the larger pharmaceutical companies, both Indian and
multi-national. The market includes pharmaceutical plants in other
countries as well.
Our business covers formulation plants for Injectables, Oral Solid
Dosage (OSD), hard and soft gelatine capsulation, oral liquid
formulations and Parenterals. Also we design plant for bulk or
multipurpose production of Active Pharmaceutical Ingredients (APIs)
and drug intermediates. A significant part of our business is
concerned with development of plant to global regulatory standards,
typically US-FDA, UK-MHRA and EU-GMP. We can assist with the
validation of plant to these standards.
Mott MacDonald is the leading designer of
pharmaceutical plants in India today
Several of our API plants have been for biotechnology products,
especially recombinant DNA insulin, for which we have also designed
sterile Injectables plants. India is a major market for such
products.
Cyto toxic APIs for treatment of cancers pose particular challenges
that we're helping the Indian pharmaceutical industry to overcome.
In this, as well as other specialist segments of the
pharmaceuticals market, we can draw on the in-house capabilities of
Mott MacDonald's experts in the UK.
As well as large plants for the production of bulk drugs and
formulation, we are also in the market for plants designed for the
testing of drugs and formulation products. We also provide services
for setting up projects for manufacturing products used for
clinical trials.
